| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| TRAMETINIB
| TRAMETINIB | ANTINEOPLASTIC | ORAL | F 72 PERCENT VD 214 LITER PPB 97.4 PERCENT Cl 4.9 LITER / HOUR HT 4.35 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN THE PH RANGE OF 2 TO 8 IN WATER | MEK1 MEK2 PDB 7JUR (CRYSTAL STRUCTURE OF KSR2:MEK1 IN COMPLEX WITH AMP-PNP AND ALLOSTERIC MEK INHIBITOR TRAMETINIB) LIGAND CODE = QOM (link to the list of PDB complexes) Download experimental 3D coordinates of QOM with added hydrogens | DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 INHIBITOR CHEMBL2964 DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 P36507 DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2 HOMO SAPIENS ENZYME KINASE PROTEIN KINASE STE STE7 | EMA | |||
